Saltar al contenido
Saltar a la información del producto
1 de 1

MABALL RITUXIMAB 500 MG 1 FAM

MABALL RITUXIMAB 500 MG 1 FAM

Precio regular $ 12,100.00 MXN
Precio en oferta $ 12,100.00 MXN Precio regular $ 14,000.00 MXN
Descuento Bajo Pedido

(Mexican Pesos)

Solo quedan 10

SKU

7703153039967

Laboratorio

HETERO

Requiere Receta:

La receta deberá enviarse al correo prescripciones@farmaciashdezsante.com para poder realizar el envío del producto.

Cadena fría:

Estimated delivery: 5–7 days from purchase.

Free shipping on orders over $2,000 MXN.

  • PayPal
Ver detalles completos

Name: MABALL

Category: HEMATOLOGY

Active ingredient: RITUXIMAB

Description: Rituximab is indicated in adult patients for the following indications: Non-Hodgkin Lymphoma (NHL) • Follicular lymphoma in treatment-naïve stage III and IV patients, in combination with chemotherapy. • Maintenance in adult patients with follicular lymphoma who have responded to induction therapy. • Relapsed or chemoresistant indolent or follicular CD20-positive B-cell non-Hodgkin lymphoma. • CD20-positive diffuse large B-cell non-Hodgkin lymphoma, in combination with CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone). Chronic Lymphocytic Leukemia (CLL) Rituximab in combination with chemotherapy is indicated for the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL). Rheumatoid arthritis (RA): Rituximab in combination with methotrexate is indicated in adult patients for: - The treatment of moderate to severe active rheumatoid arthritis when the response to disease-modifying antirheumatic drugs, including methotrexate, has been inadequate. - The treatment of moderate to severe active rheumatoid arthritis in patients with an inadequate response to, or intolerance of, one or more Tumor Necrosis Factor (TNF) inhibitor therapies. When administered in combination with methotrexate, rituximab showed a reduction in the progression index of joint damage as measured by X-ray, improved physical function, and induced a greater clinical response. Granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA). In combination with glucocorticoids, it is indicated for the treatment of patients with severely active granulomatosis with polyangiitis (GPA, also known as Wegener's granulomatosis) and microscopic polyangiitis.

Weight: 500 MG

Presentation: 1 VIAL

Recipe: YES

Cold Network: YES

Temperature: REFRIGERATED: 2°-8° C

Health Registration: 247M2021 SSA

Important Notice

The information provided by Farmacias Hernandez Santé is for informational and educational purposes only.

Remember:
  • This content is not a substitute for professional medical diagnosis, treatment, or prescription.
  • Always consult your specialist before starting, modifying, or discontinuing any treatment.
  • The proper use of medications should be supervised by a health professional.

Your well-being is our priority.